Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 83, Issue 12, Pages 1953-1967
Publisher
American Association for Cancer Research (AACR)
Online
2023-04-17
DOI
10.1158/0008-5472.can-22-3848
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
- (2023) Tommy Weiss-Sadan et al. Cell Metabolism
- TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
- (2022) Samera H. Hamad et al. ONCOGENE
- Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo
- (2021) Giorgia Foggetti et al. Cancer Discovery
- A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer
- (2021) Hongchen Cai et al. Cancer Discovery
- The Intricacies of NRF2 Regulation in Cancer
- (2021) Cody J. Schmidlin et al. SEMINARS IN CANCER BIOLOGY
- EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion
- (2021) Antonio Marzio et al. CELL
- Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction
- (2020) Yong Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microenvironmental activation of Nrf2 restricts the progression of Nrf2-activated malignant tumors
- (2020) Makiko Hayashi et al. CANCER RESEARCH
- NRF2, a Transcription Factor for Stress Response and Beyond
- (2020) Feng He et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NRF2 activation promotes aggressive lung cancer and associates with poor clinical outcomes
- (2020) Anju Singh et al. CLINICAL CANCER RESEARCH
- Dissecting the Crosstalk between NRF2 Signaling and Metabolic Processes in Cancer
- (2020) Janine M. DeBlasi et al. Cancers
- Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
- (2020) Jiangang Zhao et al. Frontiers in Oncology
- Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
- (2019) Pelin Telkoparan-Akillilar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy
- (2019) Michael R. McLoughlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
- (2019) Yun Pyo Kang et al. eLife
- Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
- (2019) Luca Lignitto et al. CELL
- Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma
- (2019) Sarah A. Best et al. Nature Communications
- Photoproximity Profiling of Protein–Protein Interactions in Cells
- (2019) David C. McCutcheon et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- NRF2 addiction in cancer cells
- (2018) Hiroshi Kitamura et al. CANCER SCIENCE
- Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
- (2018) Sarah A. Best et al. Cell Metabolism
- Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice
- (2018) Zoë N. Rogers et al. NATURE GENETICS
- Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
- (2017) Rodrigo Romero et al. NATURE MEDICINE
- A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo
- (2017) Zoë N Rogers et al. NATURE METHODS
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder
- (2017) Peter Huppke et al. Nature Communications
- Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
- (2017) Alexander Muir et al. eLife
- Activation of the NRF2 antioxidant program generates an imbalance in central carbon metabolism in cancer
- (2017) Volkan I Sayin et al. eLife
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- High-throughput Phenotyping of Lung Cancer Somatic Mutations
- (2016) Alice H. Berger et al. CANCER CELL
- NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth
- (2016) H. Satoh et al. CANCER RESEARCH
- Identification and Characterization of MCM3 as a Kelch-like ECH-associated Protein 1 (KEAP1) Substrate
- (2016) Kathleen M. Mulvaney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of KEAP1 / NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance
- (2016) Youngtae Jeong et al. Cancer Discovery
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Cancer-Derived Mutations in KEAP1 Impair NRF2 Degradation but not Ubiquitination
- (2013) B. E. Hast et al. CANCER RESEARCH
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function
- (2012) J. Ma et al. MOLECULAR AND CELLULAR BIOLOGY
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers Radioresistance
- (2010) Anju Singh et al. ANTIOXIDANTS & REDOX SIGNALING
- Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
- (2010) Hironori Satoh et al. CARCINOGENESIS
- Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features
- (2010) L. M. Solis et al. CLINICAL CANCER RESEARCH
- Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
- (2010) K. Taguchi et al. MOLECULAR AND CELLULAR BIOLOGY
- Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth
- (2010) P. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Nrf2: friend or foe for chemoprevention?
- (2009) T. W. Kensler et al. CARCINOGENESIS
- Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
- (2009) Yoo Ri Kim et al. JOURNAL OF PATHOLOGY
- Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues
- (2008) Rui Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Distinct Thresholds Govern Myc's Biological Output In Vivo
- (2008) Daniel J. Murphy et al. CANCER CELL
- PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria
- (2008) Shih-Ching Lo et al. EXPERIMENTAL CELL RESEARCH
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
- (2008) T. Shibata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started